Executive Summary
This report contains specific information regarding the installation of PermaFrost NMR® in a Carrier 19XR 
water-cooled chiller owned by Pharma Company B located in New Brunswick, NJ.
The Pharma Company B facility contact that managed the pilot was Frank Bagelio. 
In summary, The Company’s chiller treated with 
the PermaFrost NMR® ECM showed an 4.6% 
reduction in kW; a 10.7% reduction in required 
operating tonnage to deliver set point; a 8.8% 
reduction in kW/ton; an 9.6% improvement in 
COP; a 55.6% improvement in refrigerant 
approach. These results are highly significant.
The introduction of PermaFrost NMR® has 
restored a significant amount of chilled water 
performance to support this facility, which has resulted in much lower operational costs.
Based on the data collected, the return on investment (ROI) for this ECM is just 11.5 months.
Energy Science Division
Please be aware that our companies have a non-disclosure agreement in place and this document is covered under that agreement and the terms of use on our website. 
This document is not to be distributed to any third party and is not to be in the public domain without our written approval. © Copyright 2016 Powertron Global, LLC.
